Pfizer Reaffirms Transparency of COVID Vaccine Data

NEW YORK, Wednesday, September 3, 2025 – Pfizer Inc. (NYSE: PFE) today reaffirmed its commitment to transparently and consistently disclosing its research findings regarding its COVID-19 vaccine and to maintaining the integrity of those ongoing studies for all those we serve. Dr. Albert Bourla, Chairman and CEO, made the following statement: